Patent: 10,463,690
✉ Email this page to a colleague
Summary for Patent: 10,463,690
| Title: | Method and compositions for treating cancerous tumors |
| Abstract: | The present invention relates to the use of chlorine dioxide compositions for treating cancerous tumors. The present invention relates to compositions and methods for treating cancerous tumors, including naive, metastatic and recurrent cancers. The compositions comprise chlorine dioxide in an effective amount, which is injected into the cancerous tumor at least once, and often at least several times over the course of treatment. The chlorine dioxide compositions are injected directly into the cancerous tumor and the resulting tumor is effectively eliminated from the patient or subject over a period of one to several days to a few weeks, often after a single injection, or multiple injections at one session into the tumor. Often, an initial injection or multiple injections at one session are sufficient to dissolve the cancerous tumor. Often the cancer is eliminated (as evidenced by no remission) in a period of no more than several days to about two-three months and does not recur. |
| Inventor(s): | Alliger; Howard (Melville, NY) |
| Application Number: | 16/124,391 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,463,690
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Recordati Rare Diseases, Inc. | ELSPAR | asparaginase | For Injection | 101063 | January 10, 1978 | 10,463,690 | 2038-09-07 |
| Merck Teknika Llc | TICE BCG | bcg live | For Injection | 102821 | June 21, 1989 | 10,463,690 | 2038-09-07 |
| Merck Teknika Llc | N/A | bcg vaccine | For Injection | 103050 | June 21, 1989 | 10,463,690 | 2038-09-07 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
